BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lospinoso Severini L, Ghirga F, Bufalieri F, Quaglio D, Infante P, Di Marcotullio L. The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma. Expert Opin Ther Targets 2020;24:1159-81. [PMID: 32990091 DOI: 10.1080/14728222.2020.1823967] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Lospinoso Severini L, Bufalieri F, Infante P, Di Marcotullio L. Proteolysis-Targeting Chimera (PROTAC): Is the Technology Looking at the Treatment of Brain Tumors? Front Cell Dev Biol 2022;10:854352. [PMID: 35242765 DOI: 10.3389/fcell.2022.854352] [Reference Citation Analysis]
2 Gatto L, Franceschi E, Tosoni A, Di Nunno V, Bartolini S, Brandes AA. Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment? Cancers (Basel) 2022;14:333. [PMID: 35053495 DOI: 10.3390/cancers14020333] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Caimano M, Lospinoso Severini L, Loricchio E, Infante P, Di Marcotullio L. Drug Delivery Systems for Hedgehog Inhibitors in the Treatment of SHH-Medulloblastoma. Front Chem 2021;9:688108. [PMID: 34164380 DOI: 10.3389/fchem.2021.688108] [Reference Citation Analysis]
4 Bonandi E, Mori M, Infante P, Basili I, Di Marcotullio L, Calcaterra A, Catti F, Botta B, Passarella D. Design and Synthesis of New Withaferin A Inspired Hedgehog Pathway Inhibitors. Chemistry 2021;27:8350-7. [PMID: 33811701 DOI: 10.1002/chem.202100315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ray S, Chaturvedi NK, Bhakat KK, Rizzino A, Mahapatra S. Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment. Diagnostics 2022;12:61. [DOI: 10.3390/diagnostics12010061] [Reference Citation Analysis]
6 Chai JY, Sugumar V, Alshawsh MA, Wong WF, Arya A, Chong PP, Looi CY. The Role of Smoothened-Dependent and -Independent Hedgehog Signaling Pathway in Tumorigenesis. Biomedicines 2021;9:1188. [PMID: 34572373 DOI: 10.3390/biomedicines9091188] [Reference Citation Analysis]
7 Paskeh MDA, Mehrabi A, Gholami MH, Zabolian A, Ranjbar E, Saleki H, Ranjbar A, Hashemi M, Ertas YN, Hushmandi K, Mirzaei S, Ashrafizadeh M, Zarrabi A, Samarghandian S. EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects. Biomed Pharmacother 2021;146:112532. [PMID: 34906772 DOI: 10.1016/j.biopha.2021.112532] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Angrisani A, Di Fiore A, Di Trani CA, Fonte S, Petroni M, Lospinoso Severini L, Bordin F, Belloni L, Ferretti E, Canettieri G, Moretti M, De Smaele E. Specific Protein 1 and p53 Interplay Modulates the Expression of the KCTD-Containing Cullin3 Adaptor Suppressor of Hedgehog 2. Front Cell Dev Biol 2021;9:638508. [PMID: 33898425 DOI: 10.3389/fcell.2021.638508] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Consalez GG, Goldowitz D, Casoni F, Hawkes R. Origins, Development, and Compartmentation of the Granule Cells of the Cerebellum. Front Neural Circuits 2020;14:611841. [PMID: 33519389 DOI: 10.3389/fncir.2020.611841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Wang W, Shiraishi R, Kawauchi D. Sonic Hedgehog Signaling in Cerebellar Development and Cancer. Front Cell Dev Biol 2022;10:864035. [DOI: 10.3389/fcell.2022.864035] [Reference Citation Analysis]